Percutaneous stereotactic radiofrequency ablation of colorectal liver metastases

European Radiology

Volumn 22, Issue 4, 2012, Pages 930-937

  Bale, Reto ^a   Widmann, Gerlig ^a   Schullian, Peter ^a   Haidu, Marion ^a   Pall, Georg ^b   Klaus, Alexander ^a   Weiss, Helmut ^a   Biebl, Matthias ^a   Margreiter, Raimund ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Ablation; Liver tumor; Navigation; Outcome; Stereotaxy

Indexed keywords

IODIXANOL;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER RECURRENCE; CANCER SURVIVAL; COLORECTAL CANCER; CONTROLLED STUDY; DECISION MAKING; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; RECURRENCE RISK; RETROSPECTIVE STUDY; STEREOTACTIC RADIOSURGERY; SURVIVAL RATE; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; AUSTRIA; CATHETER ABLATION; COLORECTAL NEOPLASMS; FEMALE; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; STEREOTAXIC TECHNIQUES; TREATMENT OUTCOME;

EID: 84861454103     PISSN: 09387994     EISSN: 14321084     Source Type: Journal    
DOI: 10.1007/s00330-011-2314-0     Document Type: Article

References (27)

1. Hurwitz H, Fehrenbacher L, Novotny W et al (2004) Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 350:2335-2342
2. Wagner JS, Adson MA, Van Heerden JA et al (1984) The natural history of hepatic metastases from colorectal cancer. A comparison with resective treatment. Ann Surg 199:502-508
3. Choti MA, Sitzmann JV, Tiburi MF et al (2002) Trends in longterm survival following liver resection for hepatic colorectal metastases. Ann Surg 235:759-766
4. Kornprat P, Jarnagin WR, Gonen M et al (2007) Outcome after hepatectomy for multiple (four or more) colorectal metastases in the era of effective chemotherapy. Ann Surg Oncol 14:1151-1160
5. Scheele J, Stangl R, Altendorf-Hofmann A (1990) Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history. Br J Surg 77:1241-1246
6. Nordlinger B, Peschaud F, Malafosse R (2003) Resection of liver metastases from colorectal cancer - how can we improve results? Colorectal Dis 5:515-517
7. Van Cutsem E, Nordlinger B, Adam R et al (2006) Towards a pan- European consensus on the treatment of patients with colorectal liver metastases. Eur J Cancer 42:2212-2221
8. Gillams AR, LeesWR (2004) Radio-frequency ablation of colorectal liver metastases in 167 patients. Eur Radiol 14:2261-2267
9. Nicholl MB, Bilchik AJ (2008) Thermal ablation of hepatic malignancy: useful but still not optimal. Eur J Surg Oncol 34:318-323
10. Mulier S, Ni Y, Jamart J et al (2005) Local recurrence after hepatic radiofrequency coagulation: multivariate meta-analysis and review of contributing factors. Ann Surg 242:158-171
11. Widmann G, Haidu M, Schullian P, Stoffner R, Bale R (2011) Stereotactic Radiofrequency Ablation (SRFA) of liver lesions: technique effectiveness, safety, and inter-operator performance. Cardiovasc Interv Radiol. doi:10.1007/s00270-011-0200-4
12. Laeseke PF, Sampson LA, Haemmerich D et al (2005) Multiple electrode radiofrequency ablation: simultaneous production of separate zones of coagulation in an in vivo porcine liver model. J Vasc Interv Radiol 16:1727-1735
13. Lee JM, Han JK, Kim HC, Choi YH, Kim SH, Choi JY, Choi BI (2007) Switching monopolar radiofrequency ablation technique using multiple, internally cooled electrodes and a multichannel generator: ex vivo and in vivo pilot study. Invest Radiol 42:163-171
14. Bale R, Widmann G, Stoffner DI (2010) Stereotaxy: breaking the limits of current radiofrequency ablation techniques. Eur J Radiol 75:32-36
15. Bale R, Widmann G, Haidu M (2011) Stereotactic Radiofrequency Ablation- a technical note. Cardiovasc Interv Radiol 34:852-856
16. Widmann G, Schullian P, Wiedermann FJ et al (2010) Respiratory motion control for computer-assisted and robotic liver interventions. Int J Med Robot 6:343-349
17. Pawlik TM, Scoggins CR, Zorzi D et al (2005) Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg 241:715-722
18. Abdalla EK, Vauthey JN, Ellis LM et al (2004) Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 239:818-825
19. De Baere T, Elias D, Dromain C et al (2000) Radiofrequency ablation of 100 hepatic metastases with a mean follow-up of more than 1 year. Am J Roentgenol 175:1619-1625
20. Solbiati L, Livraghi T, Goldberg SN et al (2001) Percutaneous radiofrequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patients. Radiology 221:159-166
21. Sorensen SM, Mortensen FV, Nielsen DT (2007) Radiofrequency ablation of colorectal liver metastases: long-term survival. Acta Radiol 48:253-258
22. Park IJ, Kim HC, Yu CS et al (2007) Radiofrequency ablation for metachronous liver metastasis from colorectal cancer after curative surgery. Ann Surg Oncol 15:227-232
23. Reuter NP, Woodall CE, Scoggins CR et al (2009) Radiofrequency ablation vs. resection for hepatic colorectal metastasis: therapeutically equivalent? J Gastrointest Surg 13:486-491
24. Scheele J, Stangl R, Altendorf-Hofmann A (1990) Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history. Br J Surg 77:1241-1246
25. DeMatteo RP, Palese C, Jarnagin WR et al (2000) Anatomic segmental hepatic resection is superior to wedge resection as an oncologic operation for colorectal liver metastases. J Gastrointest Surg 4:178-184
26. Cady B, Jenkins RL, Steele GD Jr et al (1998) Surgical margin in hepatic resection for colorectal metastasis: a critical and improvable determinant of outcome. Ann Surg 227:566-571
27. Wong SL, Mangu PB, Choti MA et al (2010) American society of clinical oncology 2009 clinical evidence review on radiofrequency ablation of hepatic metastases from colorectal cancer. J Clin Oncol 28:493-508